Distinguishing physiological versus pathological serum NfL levels in multiple sclerosis will require serial measurements.

Smets, I; Reyes, S; Giovannoni, G

Smets, I; Reyes, S; Giovannoni, G.

Afiliación

Smets I; Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom. Electronic address: i.smets@qmul.ac.uk.
Reyes S; Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom.
Giovannoni G; Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom; Department of Neurology, The Royal London Hospital, Barts Health NHS Trust, London, United Kingdom.

Mult Scler Relat Disord ; 46: 102477, 2020 Nov.

Article en En | MEDLINE | ID: mdl-32889372

Asunto(s)

Esclerosis Múltiple; Biomarcadores; Humanos; Esclerosis Múltiple/diagnóstico; Proteínas de Neurofilamentos

Palabras clave

Biomarker; Multiple sclerosis; Neurofilament

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Esclerosis Múltiple Tipo de estudio: Diagnostic_studies Idioma: En Revista: Mult Scler Relat Disord Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google